Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Vetter, Beatrice N ^a   Orlowski, Vanessa ^a   Fransen, Katrien ^b   Niederhauser, Christoph ^c   Aubert, Vincent ^d   Brandenberger, Marcel ^e   Ciardo, Diana ^f   Dollenmaier, Gü Nter ^g   Klimkait, Thomas ^h   Regenass, Stephan ⁱ   Schmid, Patrick ^j   Schottstedt, Volkmar ^k   Suter Riniker, Franziska ^l   Yerly, Sabine ^m   Shah, Cyril ^a   Böni, Jürg ^a   Schüpbach, Jö Rg ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c Blood Transfusion Service   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e SYNLAB ACADEMY   (Germany)

^f Viollier AG   (Switzerland)

^g Center for Laboratory Medicine (ZLMSG)   (Switzerland)

^h UNIVERSITY OF BASEL   (Switzerland)

ⁱ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^j CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^k German Red Cross Blood Transfusion Service West   (Germany)

^l UNIVERSITY OF BERN   (Switzerland)

^m Children's Hospital HUG   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; STRUCTURAL PROTEIN; VIRUS RNA; DIAGNOSTIC KIT; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; RECOMBINANT PROTEIN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DENATURATION; DIAGNOSTIC TEST; GENOTYPE; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMIT OF DETECTION; NONHUMAN; PHYLOGENY; SEQUENCE ALIGNMENT; VIRUS DETECTION; VIRUS GENOME; VIRUS LIKE AGENT; AMINO ACID SEQUENCE; CHEMISTRY; DIAGNOSTIC KIT; HIV INFECTIONS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PROTEIN DENATURATION; VIRION;

AMINO ACID SEQUENCE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN DENATURATION; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; VIRION;

EID: 84908433169     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111552     Document Type: Article

References (47)

1. Le T, Wright EJ, Smith DM, He W, Catano G, et al. (2013) Enhanced CD4+ Tcell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med 368: 218-230.
2. Hecht FM, Wang L, Collier A, Little S, Markowitz M, et al. (2006) A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 194: 725-733.
3. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191: 1403-1409.
4. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, et al. (2007) High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 195: 951-959.
5. Hollingsworth TD, Anderson RM, Fraser C (2008) HIV-1 transmission, by stage of infection. J Infect Dis 198: 687-693.
6. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Aids 17: 1871-1879.
7. Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, et al. (1995) Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 35: 91-97.
8. Busch MP, Satten GA (1997) Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 102: 117-124; discussion 125-116.
9. Weber B, Fall EH, Berger A, Doerr HW (1998) Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol 36: 2235-2239.
10. Branson BM (2010) The future of HIV testing. J Acquir Immune Defic Syndr 55 Suppl 2: S102-105.
11. Eshleman SH, Khaki L, Laeyendecker O, Piwowar-Manning E, Johnson-Lewis L, et al. (2009) Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr 52: 121-124.
12. Pandori MW, Hackett J, Louie B, Vallari A, Dowling T, et al. (2009) Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol 47: 2639-2642.
13. Foley B, Apetrei C, Mizrachi I, Rambaut A, Korber B, et al. (2013) HIV Sequence Compendium 2013: Los Alamos National Laboratory.
14. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM (2008) The challenge of HIV-1 subtype diversity. N Engl J Med 358: 1590-1602.
15. st International Reference Panel for HIV-1 RNA genotypes for use in nucleic acid-based techniques. J Virol Methods 154: 86-91.
16. NIBSC (2009) WHO International Standard HIV-1 P24 Antigen NIBSC code: 90/636 Instructions for use. National Institute for Biological Standards and Control.
17. Gueudin M, Plantier JC, Lemee V, Schmitt MP, Chartier L, et al. (2007) Evaluation of the Roche Cobas TaqMan and Abbott RealTime extractionquantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 44: 500-505.
18. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.
19. Schüpbach J, Tomasik Z, Knuchel M, Opravil M, Günthard HF, et al. (2006) Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under longterm HAART. J Med Virol 78: 1003-1010.
20. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291.
21. EC (2009) European Commission decision of 3 February 2009 amending decision 2002/364/EC on common technical specifications for in vitrodiagnostic medical devices Official Journal of the European Union 108/EC.
22. Böni J, Opravil M, Tomasik Z, Rothen M, Bisset L, et al. (1997) Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS 11: F47-52.
23. Schüpbach J, Günthard H, Joos B, Fischer M, Böni J, et al. (2005) HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. J Acquir Immune Defic Syndr 40: 250-256.
24. Brinkhof MW, Böni J, Steiner F, Tomasik Z, Nadal D, et al. (2006) Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits. J Acquir Immune Defic Syndr 41: 557-562.
25. Schüpbach J (2002) Measurement of HIV-1 p24 antigen by signal-amplificationboosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Rev 4: 83-92.
26. George E, Beauharnais CA, Brignoli E, Noel F, Bois G, et al. (2007) Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti. J Clin Microbiol 45: 3416-3418.
27. Torrecilla E, Llácer Delicado T, Holguín Á (2014) New findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1. PLoS One 9: e88099.
28. Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Redman M, et al. (2002) Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 185: 905-914.
29. Christiansen CB, Jessen TE, Nielsen C, Staun-Olsen P (1996) False negative anti-HIV-1/HIV-2 ELISAs in acute HIV-2 infection. Vox Sang 70: 144-147.
30. Ritter J, Chevallier P, Peyramond D, Sepetjan M (1990) Serological markers during an acute HIV-2 infection. Vox Sang 59: 244-245.
31. Besnier JM, Barin F, Baillou A, Liard F, Choutet P, et al. (1990) Symptomatic HIV-2 primary infection. Lancet 335: 798.
32. Miedouge M, Gréze M, Bailly A, Izopet J (2011) Analytical sensitivity of four HIV combined antigen/antibody assays using the p24 WHO standard. J Clin Virol 50: 57-60.
33. Song EY, Hur M, Roh EY, Park MH, Moon HW, et al. (2012) Performances of four fourth-generation human immunodeficiency virus-1 screening assays. J Med Virol 84: 1884-1888.
34. Ly TD, Plantier JC, Leballais L, Gonzalo S, Lemée V, et al. (2012) The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection. J Clin Virol 55: 121-127.
35. Tao CM, Cho Y, Ng KP, Han X, Oh EJ, et al. (2013) Validation of the Elecsys HIV combi PT assay for screening and reliable early detection of HIV-1 infection in Asia. J Clin Virol 58: 221-226.
36. Mühlbacher A, Schennach H, van Helden J, Hebell T, Pantaleo G, et al. (2013) Performance evaluation of a new fourth-generation HIV combination antigenantibody assay. Med Microbiol Immunol 202: 77-86.
37. Briggs JA, Simon MN, Gross I, Kräusslich HG, Fuller SD, et al. (2004) The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 11: 672-675.
38. Brennan CA, Yamaguchi J, Vallari A, Swanson P, Hackett JR (2013) ARCHITECT HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates. J Clin Virol 57: 169-172.
39. Ly TD, Ebel A, Faucher V, Fihman V, Laperche S (2007) Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods 143: 86-94.
40. Conway DP, Holt M, McNulty A, Couldwell DL, Smith DE, et al. (2014) Multi- Centre Evaluation of the Determine HIV Combo Assay when Used for Point of Care Testing in a High Risk Clinic-Based Population. PLoS One 9: e94062.
41. Rosenberg NE, Kamanga G, Phiri S, Nsona D, Pettifor A, et al. (2012) Detection of acute HIV infection: a field evaluation of the determine HIV-1/2 Ag/Ab combo test. J Infect Dis 205: 528-534.
42. Kilembe W, Keeling M, Karita E, Lakhi S, Chetty P, et al. (2012) Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African adults with early HIV infection. PLoS One 7: e37154.
43. Schüpbach J, Böni J, Tomasik Z, Jendis J, Seger R, et al. (1994) Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis 170: 318-324.
44. Schüpbach J, Flepp M, Pontelli D, Tomasik Z, Lüthy R, et al. (1996) Heatmediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS 10: 1085-1090.
45. WHO (2010) WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children. World Health Organization.
46. Schüpbach J, Böni J (1993) Quantitative and sensitive detection of immunecomplexed and free HIV antigen after boiling of serum. J Virol Methods 43: 247-256.
47. Fiscus SA, Wiener J, Abrams EJ, Bulterys M, Cachafeiro A, et al. (2007) Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection. J Clin Microbiol 45: 2274-2277.